注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
BriaCell Therapeutics Corp是一家免疫腫瘤生物技術公司。該公司專注於開發增強人體自身抗癌細胞摧毀癌性腫瘤能力的療法。其主要候選藥物Bria-IMT是一種靶向免疫療法,正在開髮用於治療晚期乳腺癌。該公司專注於進行Bria-IMT的I/IIa期臨床試驗,與免疫檢查點抑製劑,如與Incyte藥物retifanlimab、抗 PD-1抗體如pembrolizumab和epacadostat等進行聯合研究。Bria-IMT是一種基因工程改造的人乳腺癌細胞系,具有免疫細胞的特性,在臨床上用作靶向免疫治療。該公司還專注於開發Bria-OTS,這是一種針對乳腺癌的現成個性化免疫療法以及針對其他癌症適應症的類似免疫療法細胞系。Bria-OTS免疫療法基於患者的HLA類型。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Martin E. Schmieg | 61 | 2020 | Independent Director |
Charles Louis Wiseman | 77 | 2014 | Founder, Principal Research Advisor & Member of Scientific Advisory Board |
Brian W. Metcalf | 77 | 2017 | Member of Scientific Advisory Board |
Douglas V. Faller | - | 2017 | Member of Scientific Advisory Board |
Maria Trojanowska | - | 2017 | Member of Scientific Advisory Board |
Vaughn C. Embro-Pantalony | 67 | 2019 | Lead Independent Director |
William V. Williams | 67 | 2016 | CEO, President & Director |
Thomas Kieber-Emmons | - | 2017 | Member of Scientific Advisory Board |
Jamieson Bondarenko | 37 | 2019 | Independent Chairman of the Board |
Cara L. Haymaker | - | 2019 | Member of Scientific Advisory Board |
Rebecca A. Taub | 71 | 2019 | Independent Director |
Alexander Kharazi | - | 2022 | Member of Scientific Advisory Board |
Massimo Cristofanilli | - | 2023 | Member of Medical Advisory Board |
Jane A. Gross | 66 | 2021 | Independent Director |
Adam M. Brufsky | - | 2023 | Member of Medical Advisory Board |
Suzanne Ostrand-Rosenberg | - | 2021 | Member of Scientific Advisory Board |
Sara A. Hurvitz | - | 2023 | Member of Medical Advisory Board |
Charles Sidman | - | 2023 | Member of Scientific Advisory Board |
Marc Lustig | 50 | 2021 | Independent Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核